(S (NP (NP (DT The) (NN challenge)) (PP (IN in) (S (VP (VBG controlling) (NP (NP (JJ stochastic) (NNS systems)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (JJ random) (NNS events)) (VP (MD can) (VP (VB set) (NP (DT the) (NN system)) (PP (IN on) (NP (JJ catastrophic) (NNS trajectories)))))))))))) (VP (VBZ is) (S (VP (TO to) (VP (VB develop) (NP (DT a) (JJ robust) (NN ability) (S (VP (TO to) (VP (VB respond) (PP (TO to) (NP (JJ such) (NNS events))) (PP (IN without) (S (VP (ADVP (RB significantly)) (VBG compromising) (NP (NP (DT the) (NN optimality)) (PP (IN of) (NP (DT the) (NN baseline) (NN control) (NN policy))))))))))))))) (. .))
(S (S (NP (NN Drug) (NN resistance)) (VP (MD can) (VP (VB emerge) (PP (IN from) (NP (NP (ADJP (NN random) (CC and) (JJ variable)) (NNS mutations)) (PP (IN in) (NP (VBN targeted) (NN cell) (NNS populations)))))))) (: ;) (S (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (DT an) (JJ appropriate) (NN dosing) (NN policy))))) (, ,) (NP (NN emergent) (JJ resistant) (NNS subpopulations)) (VP (MD can) (VP (VP (VB proliferate)) (CC and) (VP (VB lead) (PP (TO to) (NP (NN treatment) (NN failure))))))) (. .))
(S (S (NP (NNP Dynamic) (JJ feedback) (NN dosage) (NN control)) (VP (VBZ holds) (NP (RB promise)) (PP (IN in) (S (VP (VBG combatting) (NP (DT this) (NN phenomenon))))))) (, ,) (CC but) (S (NP (VBP cell) (NN population) (JJ evolutionary) (NNS dynamics)) (VP (VBP are) (ADJP (ADJP (JJ complex)) (, ,) (ADJP (JJ stochastic)) (, ,) (CC and) (ADJP (ADVP (RB often)) (ADJP (JJ high-dimensional)))) (, ,) (S (VP (VBG posing) (NP (NP (JJ significant) (NNS challenges)) (PP (TO to) (NP (NN system) (NN control)))))))) (. .))
(S (NP (DT This) (NN paper)) (VP (VBZ presents) (NP (NP (NNP CelluDose)) (, ,) (NP (NP (DT a) (JJ deep) (NN reinforcement) (VBG learning) (JJ closed-loop) (JJ dynamic) (NN control) (NN prototype)) (PP (IN for) (NP (NP (JJ automated) (NN precision) (NN drug) (VBG dosing)) (VP (VBG targeting) (NP (ADJP (JJ stochastic) (CC and) (JJ heterogeneous)) (NN cell) (NN proliferation)))))))) (. .))
(S (S (VP (VBG Developing) (NP (NP (JJ optimal) (NN dosing) (NNS schedules)) (PP (IN for) (S (VP (VBG preventing) (NP (JJ therapy-induced) (NN drug) (NN resistance)))))))) (VP (VBZ involves) (NP (NP (DT a) (NN tradeoff)) (PP (IN between) (NP (NP (NP (DT the) (JJ effective) (NN suppression)) (PP (IN of) (NP (NN emergent) (NN resistant) (NN cell) (NNS subpopulations)))) (CC and) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (JJ conservative) (NNS dosages)) (CC and) (NP (NP (DT a) (NN preference)) (PP (IN for) (NP (JJ first-line) (NNS drugs))))))))))) (. .))
(S (NP (NNP CelluDose)) (VP (VBZ is) (VP (VBN trained) (PP (IN on) (NP (NP (NN model) (NNS simulations)) (PP (IN of) (NP (NN cell) (NN population) (JJ evolutionary) (NNS dynamics))) (SBAR (WHNP (WDT that)) (S (VP (VBP combine) (NP (NP (NP (DT a) (NN system)) (PP (IN of) (NP (JJ stochastic) (JJ differential) (NNS equations)))) (CC and) (NP (NP (DT the) (JJ additional) (NN occurrence)) (PP (IN of) (NP (JJ random) (VBG perturbing) (NNS events)))))))))))) (. .))
(S (NP (NP (DT Both) (DT the) (JJ single-drug) (CC and) (NN combination) (NN therapy) (NNS policies)) (VP (VBN obtained) (PP (IN in) (NP (VBG training))))) (VP (NN exhibit) (NP (NP (DT a) (ADJP (CD 100) (NN %)) (NN success) (NN rate)) (PP (IN at) (S (VP (VP (VBG suppressing) (NP (VBN simulated) (JJ heterogeneous) (NN harmful) (NN cell) (NN growth))) (CC and) (VP (VP (VBG responding) (PP (TO to) (NP (VB diverse) (NN system) (NNS fluctuations) (CC and) (NNS perturbations))) (PP (IN within) (NP (DT the) (JJ alloted) (NN time)))) (CC and) (VP (VBG using) (NP (JJ conservative) (NN dosing))))))))) (. .))
(S (NP (NP (DT The) (NNS policies)) (VP (VBN obtained))) (VP (VBD were) (VP (VBN found) (S (VP (TO to) (VP (VB be) (ADJP (RB highly) (JJ robust) (S (VP (TO to) (VP (VB model) (NP (NP (NP (NN parameter) (NNS changes)) (CC and) (NP (NNS fluctuations))) (VP (RB not) (VBN introduced) (PP (IN during) (NP (NN training)))))))))))))) (. .))
